Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker Technology Targeting Inflammatory Disease

GlobeNewswire10/15 18:00

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation With Strong Support From Partners and Affiliates

GlobeNewswire10/07 20:30

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga09/28 00:31

Impact BioMedical Says Mark Suseck to Be Oper Chief and Todd Macko to Be CFO >IBO

Dow Jones09/23 20:05

Impact BioMedical Names Frank D. Heuszel as CEO >IBO

Dow Jones09/23 20:05

Press Release: Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

Dow Jones09/23 20:01